Hogan Lovells advises Muzinich & Co. on financing the acquisition of EHF Production by NORD Holding and 1Q Health Group
Led by Munich partner Dr. Thomas Freund, global law firm Hogan Lovells has advised lender Muzinich & Co. on the financing of the acquisition of EHF Production B.V., a leading CDMO for nutritional supplements in the Netherlands, by NORD Holding and its portfolio company 1Q Health Group.
The transaction forms part of NORD Holding’s buy-and-build strategy in the healthcare and nutraceuticals sector. Through the acquisition of EHF Production, 1Q Health Group aims to further expand its manufacturing capabilities and strengthen its position as a European contract development and manufacturing organization (CDMO) for nutritional supplements and pharmaceutical products.
Muzinich & Co. is an internationally active asset manager specializing in corporate and private credit investments.
Hogan Lovells advised Muzinich & Co. on all legal aspects of the financing. The team has extensive experience advising lenders and investors, and regularly supports complex national and cross-border financing transactions.
Hogan Lovells team for Muzinich & Co
Dr. Thomas Freund (Partner), Tiziana Daxenberger (Associate), Stefanie Grosch (Business Lawyer) (Banking & Finance, Munich);
Dr. Ingmar Dörr (Partner, Tax, Munich);
Dr. Malte Ingwersen (Counsel, Corporate M&A, Hamburg);
Wouter Jongen (Partner), Viney Akshaykumar Moerliesing (Senior Associate) (Banking & Finance, Amsterdam).
